Angewandte Chemie International Edition · 2013 · 26 citations · 26 references
MedicineMedicinal ChemistryPharmacologyCancer PharmacologyEnzymologyMolecular PharmacologyAntitumor AntibioticsEnzyme InhibitionMolecular SimilarityConserved Structural MotifsDna-drug Interactions
Duocarmycin-derived seco-cyclopropabenzindole (CBI) drugs have been shown to bind DNA and an aldehyde dehydrogenase (ALDH1A1) in lung cancer cells. The removal of the DNA-binding indole moiety results in a CBI compound that does not bind to DNA in whole cells but still exhibits remarkable cytotoxicity. This CBI compound has an increased affinity for ALDH1A1. Rh=rhodamine. As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
26
Christian W. Tornøe, Caspar Christensen, Morten Meldal · The Journal of Organic Chemistry · 2002 · 8.5K citations
Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer
Feng Jiang, Qi Qiu, Abha Khanna et al. · Molecular Cancer Research · 2009 · 797 citations · Full text
Medicine, Cell Biology, Oncology +17
Targeting Aldehyde Dehydrogenase Cancer Stem Cells in Ovarian Cancer
Charles N. Landen, Blake W. Goodman, Ashwini A. Katre et al. · Molecular Cancer Therapeutics · 2010 · 384 citations · Full text
Medicine, Cancer Biology, Oncology +16
Strategies for enzyme/prodrug cancer therapy.
Guo Xu, Howard L. McLeod · PubMed · 2001 · 278 citations
Pharmacy, Oncology, Pharmacology +15